跳至主要内容
临床试验/JPRN-UMIN000040548
JPRN-UMIN000040548已完成未知

Retrospective analysis of hyper-fractionated radiotherapy for LD-SCLC - Restrospective analysis of HFRT for LD-SCLC

Faculty of Medicine, Yamagata University0 个研究点目标入组 38 人开始时间: 2020年5月31日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Case of radiotherapy for recurrence.

研究者

发起方
Faculty of Medicine, Yamagata University

相似试验

尚未招募
2 期
A comparison of accelerated hypofractionated radiotherapy versus standard hypofractionated radiotherapy in early-stage breast cancer: a randomized controlled trialEarly stage breast cancer post breast conserving surgeryHypofractionationRadiationBreast cancer
TCTR20210403001Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn university384
已完成
不适用
Phase I-/II-study of Hyperfractionated-Accelerated Radiation Therapy plus Cetuximab plus Cisplatin chemotherapy in locally advanced inoperable squamous cell cancers of head and neckCancer
ISRCTN47339346Martin-Luther-University Halle-Wittenberg (Germany)92
进行中(未招募)
1 期
A clinical Phase I/II-study of radiation therapy (HART(hyperfractionated-accelerated radiation)) plus chemotherapy (cetuximab (CET) and cisplatin (CIS)) in locally advanced inoperable skin cancers of head and neck.Squamous cell cancer of head and neck, unresectable, locally advanced, Stage III/IVa or b (UICC, 2002)MedDRA version: 14.0Level: LLTClassification code 10060121Term: Squamous cell carcinoma of head and neckSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2005-000355-15-DEMartin-Luther-Universität Halle-Wittenberg86
尚未招募
不适用
A comparative study of surgeries done for treatment of varicosities in patients of varicose vein patients.
CTRI/2020/03/024298Department of General Surgery
进行中(未招募)
不适用
Study of fewer, larger doses of radiotherapy for men with localised prostate cancerMalignant neoplasm of prostateProstate cancerCancer
ISRCTN96894088Institute of Cancer Research46